ALLMedicine™ Atrial Flutter Center
Research & Reviews 1,198 results
https://doi.org/10.1016/j.jdiacomp.2022.108227
Journal of Diabetes and Its Complications; Handelsman Y, Bunch TJ et. al.
Jun 19th, 2022 - This post hoc analysis evaluated efficacy and safety of dronedarone in atrial fibrillation (AF) and atrial flutter (AFL) patients with/without diabetes. Patients were categorized according to baseline diabetes status. Time-to-event analyses were p...
https://clinicaltrials.gov/ct2/show/NCT04869527
Jun 16th, 2022 - To demonstrate the value and benefits of BIOTRONIK's exclusive DX technology in assessing the incidence of supraventricular arrhythmias, mainly atrial fibrillation (AF), in patients with an indication for single chamber ICDs. Effects of the DX tec...
https://clinicaltrials.gov/ct2/show/NCT05396534
Jun 16th, 2022 - Pulmonary vein isolation (PVI) remains the cornerstone of all catheter-based treatment strategies in atrial fibrillation (AF). Currently, PVI is recommended (class IA indication) after one failed or intolerant class I or III antiarrhythmic drug (A...
https://clinicaltrials.gov/ct2/show/NCT03963349
Jun 14th, 2022 - The purpose of this study is to measure the long term effectiveness,clinical benefit, and safety outcomes of catheter ablation with STSF and AI for paroxysmal atrial fibrillation (PAF) subjects up to 12-month follow-up. Subject:Up to 150 PAF subj...
https://doi.org/10.3390/ijerph19116606
International Journal of Environmental Research and Publi... Cacioppo F, Schwameis M et. al.
Jun 11th, 2022 - Patients with recurrence of atrial tachyarrhythmia after catheter ablation for atrial fibrillation or atrial flutter constitute a rapidly growing cohort, but study-driven treatment recommendations are lacking. The present study aimed to compare th...
Guidelines 3 results
https://doi.org/10.1016/j.jacc.2020.08.037
Journal of the American College of Cardiology; Heidenreich PA, Estes NAM et. al.
Dec 12th, 2020 - 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.|2020|Hei...
https://doi.org/10.1016/j.cjca.2010.11.007
The Canadian Journal of Cardiology; Cairns JA, Connolly S et. al.
Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...
https://doi.org/10.1161/CIRCULATIONAHA.107.187192
Circulation Estes NA, Halperin JL et. al.
Feb 20th, 2008 - ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the...
Drugs 201 results see all →
Clinicaltrials.gov 178 results
https://clinicaltrials.gov/ct2/show/NCT04869527
Jun 16th, 2022 - To demonstrate the value and benefits of BIOTRONIK's exclusive DX technology in assessing the incidence of supraventricular arrhythmias, mainly atrial fibrillation (AF), in patients with an indication for single chamber ICDs. Effects of the DX tec...
https://clinicaltrials.gov/ct2/show/NCT05396534
Jun 16th, 2022 - Pulmonary vein isolation (PVI) remains the cornerstone of all catheter-based treatment strategies in atrial fibrillation (AF). Currently, PVI is recommended (class IA indication) after one failed or intolerant class I or III antiarrhythmic drug (A...
https://clinicaltrials.gov/ct2/show/NCT03963349
Jun 14th, 2022 - The purpose of this study is to measure the long term effectiveness,clinical benefit, and safety outcomes of catheter ablation with STSF and AI for paroxysmal atrial fibrillation (PAF) subjects up to 12-month follow-up. Subject:Up to 150 PAF subj...
https://clinicaltrials.gov/ct2/show/NCT05404789
Jun 3rd, 2022 - UTMB has received grant funding from the Federal Aviation Administration (FAA) under the Center of Excellence for Commercial Space Transportation to investigate these topics. The concern is whether spaceflight, an already hazardous endeavor, would...
https://clinicaltrials.gov/ct2/show/NCT04118530
Jun 2nd, 2022 - We propose a registry study in hematopoietic stem cell transplant (HSCT) patients with incident atrial fibrillation/atrial flutter (AF/AFL) during the initial 30 days of transplant who will be implanted with the Medtronic Reveal Linq Implantable C...
News 198 results
https://www.mdedge.com/jcomjournal/article/252962/cardiology/early-hospital-discharge-following-pci-patients-stemi
Thai Nguyen, MD, Albert Chan, MD et. al.
Mar 21st, 2022 - Study Overview Objective: To assess the safety and efficacy of early hospital discharge (EHD) for selected low-risk patients with ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI). Design: Si.
https://www.onclive.com/view/ibrutinib-therapy-for-cll-long-term-data
Jan 20th, 2022 - William Wierda, MD, PhD: Let’s start with the updates that we’ve had available over the last year. Jackie, we can start with you and if you could sort of give us your thoughts and comments around recent updates over the last data about ibrutinib [...
https://www.onclive.com/view/ibrutinib-plus-rituximab-and-venetoclax-followed-by-risk-stratified-chemoimmunotherapy
Jan 3rd, 2022 - Preetesh Jain, MD, PhD, discusses data from the following study: Ibrutinib plus rituximab and venetoclax followed by risk-stratified observation or short-course R-hyper-CVAD [rituximab, cyclophosphamide, vincristine, doxorubicin hydrochloride, de...
https://www.mdedge.com/cardiology/article/248647/arrhythmias-ep/no-advantage-shown-laa-ligation-adjunct-pulmonary-vein
Ted Bosworth
Nov 15th, 2021 - In patients treated for persistent atrial fibrillation (AFib) with pulmonary vein antral isolation (PVAI), there was a numerical but not a statistical advantage for adjunctive left atrial appendage (LAA) ligation in a multicenter randomized trial.
https://www.mdedge.com/dermatology/article/247860/wounds/enoxaparin-induced-hemorrhagic-bullae-sites-trauma-and-endothelial
Michael L. Garner, MD, Laura G. Pruitt, MD et. al.
Oct 25th, 2021 - To the Editor: A 67-year-old man with diabetes mellitus was admitted to the hospital for exacerbation of congestive heart failure and atrial flutter with rapid ventricular response. He subsequently developed a non-ST segment elevation myocardial i.